September 23, 2019
As a lifelong Alzheimer’s researcher, Dorene Rentz sees many brain scans with amyloid plaques, a telltale sign of the disease that ravages the brains and memories of its victims.
But there’s one scan she’s unable to see: that of her husband, Ray Berggren.
Never did she think that one day her 73-year-old husband would be part of a clinical trial she helped design, whose overall cognitive outcomes she will eventually help analyze.
September 19, 2019
TIME (September 19, 2019): How I Learned to Be a Better Doctor From My Wife’s Struggle With Alzheimer’s
Arthur Kleinman, MD, is the author of The Soul of Care: The Moral Education of a Husband and a Doctor. He is one of the most renowned and influential scholars and writers on psychiatry, anthropology, global health, and cultural issues in medicine. Educated at Stanford University and Stanford Medical School, he has taught at Harvard for over forty years.
September 17, 2019
In the fall of 2011, one month shy of his 59th birthday, Steve Johanson was diagnosed with early onset Alzheimer’s disease. Faced with “his worst nightmare,” Steve, a construction project manager from Watertown, Massachusetts, and his wife Judy, a family daycare provider, decided to face the disease together. For the next six years, the couple sought advice from doctors, visited museums, took gardening classes and surrounded themselves with family. But by the spring of 2017, things had started to unravel.
September 3, 2019
Being Patient (September 3, 2019): End Stage Alzheimer’s: What to Expect and How to Build Resiliency
Alzheimer’s disease can be a long haul, with some symptoms taking years and even decades to progress. By the time a patient is in end stage Alzheimer’s, however, the signs are clear. They’ve progressed to severe dementia, and will likely need around-the-clock care for physical and mental needs.
August 30, 2019
WEARTV (August 30, 2019): Alzheimer's Foundation of American Offers Caregivers Tips Ahead of Hurricane Dorian
Do you know how to protect your loved ones with Alzheimer if a natural disaster would strike the area?
Alzheimer's Foundation of American (AFA) has created an emergency preparedness checklist for Alzheimer's caregivers in the case that a storm would strike their area.
August 30, 2019
Lewy Body Dementia (LBD) is a complex, challenging brain disorder that affects many parts of the brain. Although less known than its “cousins” Parkinson’s and Alzheimer’s, it affects 1.4 million Americans.
Where Alzheimer’s is the most common form of dementia, it is followed by LBD and then Parkinson’s. Henry Paulson, M.D., Ph. D., University of Michigan, says: “Despite the prevalence of Lewy Body Dementia, confirming it can be challenging for doctors and patients alike.”
August 26, 2019
A few years ago, John Searle thought his life as he knew it was over.
His body had slowly stopped working. He had trouble walking, he was falling down, he had bad short-term memory and, at 69, he was incontinent.
It was a pattern of decline the retired Canadian engineer from Brantford, Ontario was all too familiar with. His own sister had died of Alzheimer's in her 50s. His father had died of dementia in his early 80s. So he began to start planning for a future he would not be able to participate in.
August 16, 2019
Scientists at MIT and MGH have gained new clues into the role of the brain’s blood-brain barrier in Alzheimer’s disease. Recent research has found that damage from Alzheimer’s allows toxins to enter the brain, further harming neurons.
The results are being used to try and develop new drugs to solidify the blood-brain barrier.
August 15, 2019
INSIGHT (August 15, 2019): IKEA and the Queen of Sweden are Collaborating to Build Homes Designed to Help Those Living with Alzheimer's
August 15, 2019
Harvard SEAS (August 15, 2019): Using Math to Help Treat Alzheimer’s, Parkinson’s and Other Diseases
Protein aggregation — in which misfolded proteins clump together to form large fibrils — has been implicated in many diseases including Alzheimer’s, Parkinson’s, and type II diabetes. While the exact role these fibrils play in diseases isn’t fully understood, many of the current treatments for diseases like Alzheimer’s and Parkinson’s target the aggregation process. However, finding the right treatment protocols for these drugs, which can be toxic in large doses, is challenging.